Can GLP-1 agonists help in heart failure and severe obesity? Elizabeth Tracey reports
About this episode
The episode discusses the relationship between severe obesity and a type of heart failure, exploring the potential role of GLP-1 agonists in treatment.
There’s a relationship between severe obesity and one type of heart failure, and it looks like it’s mediated by adding more phosphate groups, a process known as phosphorylation, to proteins in heart muscle cells, specifically to units within the muscle … Can GLP-1 agonists help in heart failure and severe obesity? Elizabeth Tracey reports Read More »
People in this episode
Host: Elizabeth Tracey
Topics covered
- heart failure
- severe obesity
- GLP-1 agonists
- phosphorylation
- health
- medicine
Keywords
- GLP-1 agonists
- heart failure
- severe obesity
- phosphorylation
- health news
Mentioned in this episode
Organizations: Johns Hopkins Medicine
Products: GLP-1 agonists
More episodes of Health Newsfeed – Johns Hopkins Medicine Podcasts
- Increasing rates of obesity and severe obesity may presage increased rates of heart failure, Elizabeth Tracey reports
- Is there another benefit besides weight loss of GLP-1s in people with severe obesity? Elizabeth Tracey reports
- What is severe obesity doing to the heart muscle’s ability to contract? Elizabeth Tracey reports
- How is obesity related to a common form of heart failure? Elizabeth Tracey reports
- A model of your brain may one day be grown in a lab, Elizabeth Tracey reports
- What can be learned from what cells dispose of? Elizabeth Tracey reports
Explore listener stats, chart rankings, contacts and more on the Health Newsfeed – Johns Hopkins Medicine Podcasts podcast page.